Estrogen receptor-positive breast cancer
What is Estrogen receptor-positive breast cancer?
Estrogen receptor-positive breast cancer is the most common type of breast cancer. This cancer has cells with proteins called estrogen receptors on their surface. When estrogen binds to these receptors, it signals the cancer cells to grow and multiply. About 70 percent of breast cancers are estrogen receptor-positive.
This type of cancer responds to the hormone estrogen as fuel for growth. Women who have this cancer often benefit from treatments that block estrogen or lower estrogen levels in the body. Understanding your estrogen levels can help guide treatment decisions and monitoring.
Estrogen receptor-positive breast cancer can occur in women of all ages. It is more common in women after menopause. Early detection through screening and monitoring hormone levels can improve treatment outcomes. Blood tests measuring estrogen can help doctors track how well treatments are working.
Symptoms
- A new lump or mass in the breast or underarm area
- Thickening or swelling of part of the breast
- Dimpling or irritation of breast skin
- Redness or flaky skin in the nipple area or the breast
- Pulling in of the nipple
- Nipple discharge other than breast milk
- Any change in the size or shape of the breast
- Pain in any area of the breast
Some women with early breast cancer have no noticeable symptoms at all. This is why regular screening mammograms are important for early detection.
Concerned about Estrogen receptor-positive breast cancer? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Estrogen receptor-positive breast cancer develops when breast cells with estrogen receptors begin to grow abnormally. Exposure to estrogen over a lifetime increases risk. This includes early menstruation before age 12, late menopause after age 55, never being pregnant, or first pregnancy after age 30. Taking hormone replacement therapy that combines estrogen and progesterone also raises risk.
Other risk factors include family history of breast cancer, inherited gene mutations like BRCA1 and BRCA2, obesity, drinking alcohol, and lack of physical activity. Women with dense breast tissue have higher risk. Age is also a major factor, as risk increases after age 50. While these factors raise risk, many women with estrogen receptor-positive breast cancer have no known risk factors.
How it's diagnosed
Doctors diagnose breast cancer through several methods. Mammograms can detect lumps or abnormal areas in breast tissue. If something suspicious appears, a biopsy removes a small tissue sample for laboratory testing. The lab tests the cancer cells to see if they have estrogen receptors. This determines if the cancer is estrogen receptor-positive.
Blood tests measuring estrogen levels, specifically estradiol, can help monitor treatment effectiveness and disease progression. Rite Aid offers estradiol testing through our preventive health service at Quest Diagnostics locations nationwide. Elevated estradiol levels can stimulate the growth of estrogen receptor-positive cancer cells. Regular monitoring helps your care team adjust treatment as needed.
Treatment options
- Hormone therapy medications that block estrogen receptors, such as tamoxifen or raloxifene
- Aromatase inhibitors that reduce estrogen production in postmenopausal women, such as anastrozole, letrozole, or exemestane
- Surgery to remove the tumor or entire breast, depending on cancer stage and spread
- Radiation therapy to kill remaining cancer cells after surgery
- Chemotherapy for more advanced or aggressive cancers
- Maintaining a healthy weight through balanced nutrition and regular physical activity
- Limiting alcohol consumption to reduce risk of recurrence
- Regular exercise, at least 150 minutes of moderate activity per week
- Eating a diet rich in vegetables, fruits, whole grains, and lean proteins
- Regular follow-up appointments and monitoring with your oncology team
Need testing for Estrogen receptor-positive breast cancer? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Estrogen receptor-positive means the cancer cells have proteins called estrogen receptors on their surface. Estrogen hormones can attach to these receptors and signal the cancer to grow. About 70 percent of breast cancers are estrogen receptor-positive. This type responds well to hormone-blocking treatments.
This type of breast cancer grows in response to estrogen, while other types may be fueled by progesterone or HER2 protein. Estrogen receptor-positive cancers usually grow more slowly than other types. They also tend to respond well to hormone therapy treatments that block estrogen. Knowing your cancer type helps doctors choose the most effective treatment.
Blood tests cannot diagnose breast cancer directly. Only a tissue biopsy can confirm cancer and determine if it is estrogen receptor-positive. However, blood tests measuring estradiol levels can help monitor treatment effectiveness once diagnosed. High estradiol levels can stimulate the growth of estrogen receptor-positive cancer cells.
Hormone therapy is often the primary treatment after surgery. Medications like tamoxifen block estrogen from reaching cancer cells. Aromatase inhibitors reduce estrogen production in postmenopausal women. Surgery, radiation, and sometimes chemotherapy may also be part of your treatment plan. Your oncologist will create a personalized treatment strategy based on your specific situation.
Your oncologist will determine the monitoring schedule based on your treatment plan. Some patients need testing every few months, while others need less frequent monitoring. Regular blood tests help ensure hormone-blocking treatments are working effectively. Tracking estradiol levels over time shows how your body responds to therapy.
Yes, lifestyle changes can support your treatment and reduce recurrence risk. Maintaining a healthy weight is important because fat tissue produces estrogen. Regular exercise and a plant-rich diet may help lower estrogen levels. Limiting alcohol and avoiding smoking also support better outcomes. Always discuss lifestyle changes with your care team.
Estrogen receptor-positive breast cancer generally has a good prognosis, especially when caught early. Five-year survival rates for early-stage disease are over 90 percent with proper treatment. The cancer usually grows more slowly than other types. Response to hormone therapy also improves long-term outcomes for most patients.
Most patients take hormone therapy for five to 10 years after initial treatment. Some women may benefit from longer treatment depending on their cancer characteristics and recurrence risk. Your oncologist will regularly assess whether continuing therapy provides more benefit than risk. Treatment duration is personalized based on your individual situation.
Yes, there is a risk of recurrence even after successful treatment. This is why long-term hormone therapy and regular monitoring are important. Estrogen receptor-positive cancers can sometimes return years after initial treatment. Maintaining healthy lifestyle habits and staying vigilant with follow-up care helps catch any recurrence early.
Foods containing plant estrogens, called phytoestrogens, are generally safe and may even be protective. Soy products, flaxseeds, and many vegetables contain phytoestrogens that are much weaker than human estrogen. Research suggests these foods do not increase recurrence risk. Focus on a balanced diet rich in whole foods rather than restricting specific items unnecessarily.